Transfer of Blastocysts in cryopreseved cycles

Not Applicable

• Conditions: Infertility.; Complication associated with artificial fertilization, unspecified; N98.9

• Registration Number: IRCT201107306420N7
• Lead Sponsor: Yazd research and clinical center for infertility

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 150

Inclusion Criteria

women underwent previously in vitro fertilization (IVF) or intra-cytoplasmicsperm injection (ICSI) with embryo cryopreservation

Exclusion Criteria

History of diabetes mellitus
Thyroid disease
Severe endometriosis
Oocyte donation cycles
Women with age>35 years
Body mass index (BMI)>30 kg/m2

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: Blood laboartory kit.;Clinical pregnancy. Timepoint: 5 weeks after positive beta-hCG. Method of measurement: Observation of fetal heart activity by transvaginal ultrasonography.;Ongoing pregnancy. Timepoint: 12 weeks after embryo transfer. Method of measurement: Ultrasonography.

Secondary Outcome Measures

Name	Time	Method
Miscarriage rate. Timepoint: Lost of pregnancy before 20 gestational week. Method of measurement: Absence of fetal heart activity in ultra sound sonography.